Emily McKeen
Nurse Practitioner · Buffalo, NYNPI 1548853484
Payments from drug & device makers
Across 103 payments — averaging $18.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$576
- Novo Nordisk$293
- AstraZeneca$243
- GSK$139
- Amgen$125
- Abbott$115
- plus $438 from 11 others
What the payments were for
- Food & beverage$1,928100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $576 |
| Novo Nordisk | 19 | $293 |
| AstraZeneca | 16 | $243 |
| GSK | 10 | $139 |
| Amgen | 1 | $125 |
| Abbott | 1 | $115 |
| Pfizer | 6 | $107 |
| Insulet Corporation | 4 | $80 |
| Dexcom, Inc. | 4 | $54 |
| Lilly USA, LLC | 3 | $41 |
| Mannkind Corporation | 2 | $32 |
| Scilex Pharmaceuticals Inc. | 2 | $27 |
| Eisai Inc. | 2 | $26 |
| Mylan Specialty L.p. | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Almatica Pharma LLC | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$125
- FreeStyle Libre Pro$115
How this compares
$1,928 in reported general payments places this provider in the 90th percentile of 4,112 nurse practitioner providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 46 | $59,692 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 70 | $45,134 |
| FarxigaDapagliflozin Propanediol | 15 | $17,607 |
| JardianceEmpagliflozin | 18 | $12,832 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $10,868 |
| LinzessLinaclotide | 11 | $10,211 |
| XareltoRivaroxaban | 18 | $10,004 |
| EliquisApixaban | 14 | $8,088 |
| JanuviaSitagliptin Phosphate | 12 | $6,919 |
| SymbicortBudesonide/Formoterol Fumarate | 20 | $4,514 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $2,333 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $2,034 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 58 | $1,516 |
| Gabapentin | 129 | $1,454 |
| Omeprazole | 91 | $1,158 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $293 | $59,69246 claims |
| GSKTrelegy Ellipta | $139 | $45,13470 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $243 | $32,98952 claims |
| Boehringer IngelheimJardiance | $20 | $12,83218 claims |
| AbbVieLinzess | $576 | $10,21111 claims |
| PfizerEliquis | $107 | $8,08814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,112 nurse practitioner providers in New York.
Other nurse practitioner in Buffalo
- Maureen GearyBuffalo$16K
- Maggie ZieboldBuffalo$11K
- Patricia McGoldrickNew York$202K
- Michelle DartSyracuse$95K
- Susan KreppelWilliamsville$67K
- Kerry AhernEast Syracuse$55K
- Valerie StanleyAlbany$55K
- Jodi LogerfoNew York$48K
- Grace WlasowiczRochester$41K
- Melissa LevinElmhurst$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.